|
Security
Type
|
Security
Class
Title
|
Fee
Calculation
Rule
|
Amount
Registered(1)
|
Proposed
Maximum
Offering Price
Per Unit
|
Maximum
Aggregate
Offering
Price
|
Fee Rate
|
Amount of
Registration
Fee
|
|||||||||||||||
|
Equity
|
Common Stock, par value
$0.00033
|
Rule 457(c) and Rule
457(h)
|
2,400,000
|
(2)
|
$
|
4.6804
|
(3)
|
$
|
11,232,960
|
(3)
|
$
|
0.00014760
|
$
|
1,657.98
|
||||||||
|
Total Offering Amounts
|
$
|
11,232,960
|
$
|
1,657.98
|
||||||||||||||||||
|
Total Fee Offsets(4)
|
-
|
|||||||||||||||||||||
|
Net Fee Due
|
$
|
1,657.98
|
||||||||||||||||||||
| (1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 shall cover any additional shares of common stock, $0.00033 par value per share
(“Common Stock”) of the Registrant that become issuable under the Third Amended and Restated PDS Biotechnology Corporation 2014 Equity Incentive Plan, as amended (the “2014 Plan”) by reason of any stock dividend, stock split,
recapitalization, or other similar transaction effected without the Registrant’s receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock.
|
| (2) |
Consists of shares of Common Stock under the 2014 Plan.
|
| (3) |
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the
Registrant’s Common Stock as reported on the Nasdaq on November 7, 2023.
|
| (4) |
The Registrant does not have any fee offsets.
|